We are live on ! Find out more
IART icon

Integra LifeSciences
IART

249 hedge funds and large institutions have $4.87B invested in Integra LifeSciences in 2018 Q3 according to their latest regulatory filings, with 36 funds opening new positions, 96 increasing their positions, 84 reducing their positions, and 40 closing their positions.

New
Increased
Maintained
Reduced
Closed

14% more repeat investments, than reductions

Existing positions increased: 96 | Existing positions reduced: 84

14% more call options, than puts

Call options by funds: $7.57M | Put options by funds: $6.64M

4.26% more ownership

Funds ownership: 82.58% → 86.85% (+4.3%)

4% more capital invested

Capital invested by funds: $4.67B → $4.87B (+$195M)

0% more funds holding in top 10

Funds holding in top 10: 3 → 3 (0)

3% less funds holding

Funds holding: 257 → 249 (-8)

10% less first-time investments, than exits

New positions opened: 36 | Existing positions closed: 40

Holders
249
Holders Change
-8
Holders Change %
-3.11%
% of All Funds
5.69%
Holding in Top 10
3
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.07%
New
36
Increased
96
Reduced
84
Closed
40
Calls
$7.57M
Puts
$6.64M
Net Calls
+$933K
Net Calls Change
-$658K

Top Buyers

1
Wellington Management Group
Wellington Management Group
Massachusetts
+$87.4M
2
Capital World Investors
Capital World Investors
California
+$57.5M
3
Fidelity Investments
Fidelity Investments
Massachusetts
+$35.6M
4
Capital Research Global Investors
Capital Research Global Investors
California
+$26.3M
5
First Trust Advisors
First Trust Advisors
Illinois
+$20M

Top Sellers

1
Goldman Sachs
Goldman Sachs
New York
-$46.5M
2
Wells Fargo
Wells Fargo
California
-$33.5M
3
GT
Glenmede Trust
Pennsylvania
-$26.3M
4
Dimensional Fund Advisors
Dimensional Fund Advisors
Texas
-$20.6M
5
Millennium Management
Millennium Management
New York
-$19.4M
Name Holding Trade Value Shares
Change 		Change in
Stake
Fidelity Investments
1
Fidelity Investments
Massachusetts
$767M +$35.6M +572,857 +5%
Capital Research Global Investors
2
Capital Research Global Investors
California
$671M +$26.3M +423,324 +4%
BlackRock
3
BlackRock
New York
$429M +$6.7M +107,781 +2%
Vanguard Group
4
Vanguard Group
Pennsylvania
$403M -$10.8M -173,390 -3%
CIP
5
Champlain Investment Partners
Vermont
$352M +$13.1M +211,115 +4%
Wellington Management Group
6
Wellington Management Group
Massachusetts
$255M +$87.4M +1,407,050 +57%
State Street
7
State Street
Massachusetts
$144M +$9.5M +152,857 +7%
Janus Henderson Group
8
Janus Henderson Group
United Kingdom
$132M +$2.66M +42,790 +2%
ClearBridge Investments
9
ClearBridge Investments
New York
$119M +$8.25M +132,805 +8%
Invesco
10
Invesco
Georgia
$75.3M +$638K +10,273 +0.9%
Capital World Investors
11
Capital World Investors
California
$74.9M +$57.5M +926,015 +439%
Jennison Associates
12
Jennison Associates
New York
$66.6M -$202K -3,247 -0.3%
Fisher Asset Management
13
Fisher Asset Management
Washington
$61.9M -$359K -5,777 -0.6%
Dimensional Fund Advisors
14
Dimensional Fund Advisors
Texas
$50M -$20.6M -331,432 -30%
Bank of New York Mellon
15
Bank of New York Mellon
New York
$49.5M +$469K +7,547 +1%
Westfield Capital Management
16
Westfield Capital Management
Massachusetts
$48.7M +$5.68M +91,395 +14%
Norges Bank
17
Norges Bank
Norway
$46.9M – – –
O
18
OppenheimerFunds
New York
$46.2M +$6.04M +97,243 +16%
Geode Capital Management
19
Geode Capital Management
Massachusetts
$45.6M +$1.44M +23,155 +3%
Lord, Abbett & Co
20
Lord, Abbett & Co
New Jersey
$42.9M +$4.82M +77,612 +14%
ACM
21
Atlanta Capital Management
Georgia
$42.4M +$259K +4,168 +0.7%
Northern Trust
22
Northern Trust
Illinois
$39.6M -$3.4M -54,745 -8%
D.E. Shaw & Co
23
D.E. Shaw & Co
New York
$29.8M -$3.71M -59,730 -12%
Charles Schwab
24
Charles Schwab
California
$29.2M +$8.67M +139,546 +46%
Royal Bank of Canada
25
Royal Bank of Canada
Ontario, Canada
$29M -$4.78M -76,949 -15%
1
2 3 4 5

IART Hedge Fund Activity: Q3 2018 in Review

249 of the 4,374 institutional investors tracked by Wall St. Rank reported a position in Integra LifeSciences (IART) for Q3 2018, worth a combined $4.87B — up 4.2% from $4.67B a quarter earlier.

Sellers outnumbered buyers: 40 funds closed out of IART and 36 opened new positions — a net loss of 4 holders — while 84 trimmed existing stakes and 96 added.

The largest buyer was Wellington Management Group, adding an estimated $87.4M. The largest seller was Goldman Sachs, cutting an estimated $46.5M.

  • 249 institutional investors held Integra LifeSciences (IART) as of Q3 2018, down from 257 in Q2 2018.
  • Funds reported $4.87B of Integra LifeSciences stock for Q3 2018, up 4.2% quarter-over-quarter.
  • 36 funds opened new Integra LifeSciences positions in Q3 2018 and 40 closed out, a net change of -4 holders.
  • The largest Integra LifeSciences buyer in Q3 2018 was Wellington Management Group, an estimated $87.4M added.
  • The largest Integra LifeSciences seller in Q3 2018 was Goldman Sachs, an estimated $46.5M sold.

Based on aggregated 13F filings for Q3 2018.